Participants, diagnosed within the past three years, maintaining stable doses of symptomatic medications (dopamine agonist and/or L-dopa and/or MAO-B inhibitor) without motor complications, were randomly allocated in a 1:1 ratio to receive daily subcutaneous injections of either Lixisenatide or placebo over a period of 12 months
Follow the prescribing clinicians plan, ask about refills before running out, and do not change dose without medical guidance
Kidney Trouble Your kidneys can take a hit, particularly if you're getting dehydrated from nausea, vomiting, or diarrhea
Dr Alison Cave, MHRA chief safety officer, said that new medicines, such as tirzepatide, are more intensively monitored to ensure any new safety issues are identified promptly
Neuropsychobiology 2003;47:94-7
Vitastir has great products and use a great FDA-approved pharmacy VITASTIR IS ALWAYS FABULOUS